Form 4: Accolade CEO Rajeev Singh Reports Stock Transactions
SEC Form 4 Filing
Rajeev Singh, CEO of Accolade, Inc., reports the conversion of Restricted Stock Units (RSUs) and subsequent sale of shares to cover tax obligations.
Summary
- Rajeev Singh, the CEO of Accolade, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On March 11, 2024, 1,650 Restricted Stock Units (RSUs) converted into common stock.
- On March 12, 2024, Mr. Singh sold 662 shares of common stock at a price of $9.524 per share.
- The sale was to cover tax withholding obligations related to the vesting and settlement of the RSUs.
- Following these transactions, Mr. Singh directly owns 745,191 shares of Accolade, Inc. common stock and indirectly owns 651,619 shares through Avanti Holdings, LLC.
- He also holds 24,751 Restricted Stock Units.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions for tax purposes, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates the CEO's transactions related to vested stock awards and tax obligations.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholders, but it is primarily related to tax obligations and not a discretionary sale.
Key Dates
| Date | Description |
|---|---|
| June 10, 2022 | June 2022 RSU Vesting Commencement Date |
| 03/11/2024 | Conversion of Restricted Stock Units to Common Stock |
| 03/12/2024 | Sale of Common Stock to cover tax obligations |
| 03/13/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.